Dr. Kurt Devine and Dr. Heather Bell
Dr. Kurt Devine and Dr. Heather Bell
Episode 96 - Buprenorphine Monoproduct (Subutex) Secondary to Adverse Events with bup/naloxone (Suboxone)
Episode 96 - Buprenorphine Monoproduct (Subutex) Secondary to Adverse Events with bup/naloxone (Suboxone)
Episode 96 - Buprenorphine Monoproduct (Subutex) Secondary to Adverse Events with bup/naloxone (Suboxone)
Tuesday 5th April 2022
Drs. Bell and DeVine discuss transitioning from Suboxone to Subutex for patients with adverse events, covering risks, benefits, and guidelines.
22 minutes
Informative
Supportive
Engaging
Thought-provoking
Authentic
About this podcast
Author:
Dr. Kurt Devine and Dr. Heather Bell
Overview:
Categories:
Understanding Addiction & Recovery
Navigating Alcohol Dependency
Navigating Intimate Relationships
Family Recovery from Addiction
Nutritional Pathways to Recovery
Links:
Visit site
Episodes:
207 (View all)
Do you want to link to this podcast?
Get the buttons here!Suboxone to Subutex: Weighing the Risks and Benefits
We like to believe the opposite of addiction is actually connection and we are going to attempt to educate you and possibly even entertain you while we navigate all topics.
Have you ever wondered what happens when a patient experiences adverse events with buprenorphine-naloxone (Suboxone)? In this episode of 'The Addiction Connection', Drs. Heather Bell and Kurt DeVine tackle this very issue. They dive into the guidelines and literature to explore the alternative of transitioning to buprenorphine monoproduct (Subutex) instead of the more commonly recommended methadone. But is this switch always the best choice? The doctors weigh the risks and benefits, offering their own insights and experiences along the way.
They also touch on important considerations like the plasma-urine discrepancy and the prescriber's risk assessment. To round things off, they discuss issues related to diversion and access to treatment, making this episode a must-listen for anyone interested in the complexities of addiction treatment.